Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Roxana Cristina, Rimbas"'
Autor:
Ionela‐Simona Visoiu, Roxana Cristina Rimbas, Alina Ioana Nicula, Dragos Vinereanu, Bjarke Jensen
Publikováno v:
Physiological Reports, Vol 12, Iss 12, Pp n/a-n/a (2024)
Abstract Numerous diagnostic criteria for excessive trabeculation, or “noncompaction,” score the extent of the trabecular layer. Whether the trabeculations themselves have a poor or good contractility is largely unknown. We retrospectively analyz
Externí odkaz:
https://doaj.org/article/f6cd5496db974598b826972e8459a27e
Autor:
Miruna Stefan, Roxana Cristina Rimbas, Rozina Vornicu, Ruxandra Daneţ, Vlad Damian Vintila, Bogdan Dorobat, Alexandra Carp, Vinereanu Dragos
Publikováno v:
Arquivos Brasileiros de Cardiologia, Vol 118, Iss 2, Pp 530-535 (2022)
Externí odkaz:
https://doaj.org/article/74c37af18d094e8dbef1593be044d218
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 2, Pp 283-302 (2021)
Cardiac amyloidosis (CA) still represents a frequently missed cause of heart failure with preserved ejection fraction (HFpEF). In the light of many new and effective therapies for immunoglobulin light chain amyloidosis (AL) and for transthyretin amyl
Externí odkaz:
https://doaj.org/article/571202ba31c64780963bcd5867b17303
Autor:
Andreea-Antonia NICA, Andrea-Olivia CIOBANU, Roxana-Cristina RIMBAS, Alexandru VASILESCU, Vlad VINTILA, Dragos Vinereanu
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 2, Pp 367-372 (2021)
Valvular heart disease affects more that 100 million people worldwide. Valvular replacement remains the only definite treatment for most of the patients with severe disease. Careful medical management and periodic follow up of valve function is manda
Externí odkaz:
https://doaj.org/article/fbc66c5c18794ccb9413fc01890913d8
Autor:
Alexandra Maria Chitroceanu, Alina Ioana Nicula, Roxana Cristina Rimbas, Mihaela Andreescu, Cristina Popp, Claudiu Stoicescu, Dragos Vinereanu
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 1, Pp 102-110 (2021)
AL (light chain) amyloidosis is a life threatening disease. Untreated patients with involvement of the heart, a condition known as cardiac amyloidosis (CA), tend to have the most rapid disease progression and worst prognosis. Therefore, it is essenti
Externí odkaz:
https://doaj.org/article/9c64488be89e41ab8742d99c40fce2c8
Autor:
Ionela Simona Visoiu, Roxana Cristina Rimbas, Loredana Gheorghiu, Ruxandra Dragoi Galrinho Antunes Guerra, Alina Ioana Nicula, Dragos Vinereanu
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 1, Pp 122-128 (2021)
Left ventricular non-compaction (LVNC) is an increasingly recognized phenotype. The current definition of the LVNC does not mention LV dysfunction as an absolute criterion in addition to morphological criteria. LV dilatation and decreased LV ejection
Externí odkaz:
https://doaj.org/article/84014a01771646e3bea86ab8fb36450a
Autor:
Roxana Cristina Rimbas, Ionela Simona Visoiu, Stefania Lucia Magda, Sorina Mihaila-Baldea, Maria Luiza Luchian, Alexandra Maria Chitroceanu, Memis Hayat, Diana Janina Mihalcea, Ruxandra Dragoi-Galrinho-Antunes-Guerra, Miruna Stefan, Andreea Velcea, Anca Andreea Andronic, Laura Lungeanu-Juravle, Alina Ioana Nicula, Dragos Vinereanu
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0267962 (2022)
AimsNone of the conventional echocardiographic parameters alone predict increased NTproBNP level and symptoms, making diagnosis of heart failure with preserved ejection fraction (HFpEF) very difficult in some cases, in resting condition. We evaluated
Externí odkaz:
https://doaj.org/article/30d7ca7c04774d10bf58e603370bc8cf
Publikováno v:
Anatolian Journal of Cardiology, Vol 24, Iss 5, Pp 5014-5016 (2020)
Externí odkaz:
https://doaj.org/article/1accd8f3e58d49b2b5b873d68885e08c
Autor:
Alexandru Vasilescu, Andreea-Antonia Nica, Andrea-Olivia Ciobanu, Dragos Vinereanu, V. Vintila, Roxana-Cristina Rimbas
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 2, Pp 367-372 (2021)
Valvular heart disease affects more that 100 million people worldwide. Valvular replacement remains the only definite treatment for most of the patients with severe disease. Careful medical management and periodic follow-up of valve function is manda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd9ecf4c093c7f20fcbf8f75181ee9be
https://doi.org/10.47803/rjc.2021.31.2.367
https://doi.org/10.47803/rjc.2021.31.2.367
Autor:
Mihaela Andreescu, Alexandra Maria Chitroceanu, Dragos Vinereanu, Claudiu Stoicescu, Cristina Popp, Roxana Cristina Rimbas, Alina Ioana Nicula
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 1, Pp 102-110 (2021)
AL (light chain) amyloidosis is a life threatening disease. Untreated patients with involvement of the heart, a condition known as cardiac amyloidosis (CA), tend to have the most rapid disease progression and worst prognosis. Therefore, it is essenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::953b5046727541a09dd6d903118e645d
https://www.romanianjournalcardiology.ro/wp-content/uploads/2021/03/RRC_art-15.pdf
https://www.romanianjournalcardiology.ro/wp-content/uploads/2021/03/RRC_art-15.pdf